Literature DB >> 16157303

Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury.

Esra Nutku1, Sherry A Hudson, Bruce S Bochner.   

Abstract

Sialic acid binding immunoglobulin like lectin (Siglec)-8 crosslinking with specific antibodies causes human eosinophil apoptosis. Mechanisms by which Siglec-8 crosslinking induces apoptosis are not known. Peripheral blood eosinophils were examined for caspase, mitochondria and reactive oxygen species (ROS) involvement after incubating the cells with anti-Siglec-8 crosslinking Abs or control Abs, in the presence or absence of selective inhibitors. Siglec-8 crosslinking induced rapid cleavage of caspase-3, caspase-8, and caspase-9 in eosinophils. Selective caspase-8 and/or caspase-9 inhibitors inhibited this apoptosis. Siglec-8 crosslinking on eosinophils increased dissipation of mitochondrial membrane potential upstream of caspase activation. Rotenone and antimycin, inhibitors of mitochondrial respiratory chain components, completely inhibited apoptosis. Additional experiments with an inhibitor of ROS, diphenyleneiodonium, demonstrated that ROS was also essential for Siglec-8-mediated apoptosis and preceded Siglec-8-mediated mitochondrial dissipation. These experiments show that Siglec-8-induced apoptosis occurs through the sequential production of ROS, followed by induction of mitochondrial injury and caspase cleavage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157303     DOI: 10.1016/j.bbrc.2005.08.202

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  39 in total

1.  Developmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expression.

Authors:  Sherry A Hudson; Harald Herrmann; Jian Du; Paul Cox; El-Bdaoui Haddad; Barbara Butler; Paul R Crocker; Steven J Ackerman; Peter Valent; Bruce S Bochner
Journal:  J Clin Immunol       Date:  2011-09-22       Impact factor: 8.317

2.  IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils.

Authors:  Ho Jeong Na; Sherry A Hudson; Bruce S Bochner
Journal:  Cytokine       Date:  2011-11-12       Impact factor: 3.861

Review 3.  Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression.

Authors:  Robert P Schleimer; Ronald L Schnaar; Bruce S Bochner
Journal:  Curr Opin Allergy Clin Immunol       Date:  2016-02

4.  Mice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation.

Authors:  Takumi Kiwamoto; Mary E Brummet; Fan Wu; Mary G Motari; David F Smith; Ronald L Schnaar; Zhou Zhu; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2013-07-02       Impact factor: 10.793

5.  Airway glycomic and allergic inflammatory consequences resulting from keratan sulfate galactose 6-O-sulfotransferase (CHST1) deficiency.

Authors:  Tadahiro Kumagai; Takumi Kiwamoto; Mary E Brummet; Fan Wu; Kazuhiro Aoki; Zhou Zhu; Bruce S Bochner; Michael Tiemeyer
Journal:  Glycobiology       Date:  2018-06-01       Impact factor: 4.313

Review 6.  Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.

Authors:  B S Bochner
Journal:  Clin Exp Allergy       Date:  2009-03       Impact factor: 5.018

Review 7.  Basic and clinical immunology of Siglecs.

Authors:  Stephan von Gunten; Bruce S Bochner
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

8.  Polymorphisms in the sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) gene are associated with susceptibility to asthma.

Authors:  Pei-Song Gao; Kenichi Shimizu; Audrey V Grant; Nicholas Rafaels; Lin-Fu Zhou; Sherry A Hudson; Satoshi Konno; Nives Zimmermann; Maria I Araujo; Eduardo V Ponte; Alvaro A Cruz; Masaharu Nishimura; Song-Nan Su; Nobuyuki Hizawa; Terry H Beaty; Rasika A Mathias; Marc E Rothenberg; Kathleen C Barnes; Bruce S Bochner
Journal:  Eur J Hum Genet       Date:  2010-01-20       Impact factor: 4.246

9.  Eosinophil survival and apoptosis in health and disease.

Authors:  Yong Mean Park; Bruce S Bochner
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

10.  Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils.

Authors:  N Zimmermann; M L McBride; Y Yamada; S A Hudson; C Jones; K D Cromie; P R Crocker; M E Rothenberg; B S Bochner
Journal:  Allergy       Date:  2008-09       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.